A Safer Blood Thinner? 

This novel blood clot treatment doesn't increase bleeding risk

Health & Lifestyle
203

Listen to article (english)

Translate to Spanish or other 102 languages!

Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound. Image for illustration purposes
Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound. Image for illustration purposes

Medical News Today

- Advertisement -
  • While anticoagulants are important for preventing dangerous blood clots, they increase the risk of excessive bleeding.
  • Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound.
  • Rather than target all clotting pathways to prevent thrombosis, the new compound strategically targets just one, so clotting continues but without a bleeding risk or toxicity.

Anticoagulants, or blood thinners, break down and prevent blood clots, semi-solid clumps of blood cells, and other substances that can block blood flow. However, anticoagulants can do their job too well, preventing clotting altogether and resulting in excessive external or internal bleeding.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/blood-thinner-potential-blood-clot-treatment-lower-bleeding-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-05-02&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Hispanic People – Especially Men – Are Less Likely to See a Doctor
Next article
Why Young Women Have More Adverse Outcomes After a Heart Attack Than Young Men

More Articles

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.

Three Everyday Habits That Could Be Ruining Your Sleep

 If you struggle to get a good night’s sleep, you may want to look at some of your habits – like what time you actually go to bed.

When GLP‑1s Fall Short

Over the last few years, glucagon-like peptide-1 (GLP-1) receptor agonistsTrusted Source have been growing in popularity for not only treating type 2 diabetes but also for weight loss. 
- Advertisement -